Medicare Enrolled

Dr. Tayson Delengocky, D.O

Ophthalmology · Chula Vista, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
835 3RD AVE, Chula Vista, CA 91911
6194257755
In practice since 2007 (18 years)
NPI: 1164637153 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Delengocky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Delengocky? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Delengocky

Dr. Tayson Delengocky is an ophthalmology specialist in Chula Vista, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Delengocky performed 8,395 Medicare services across 6,829 unique beneficiaries.

Between the years covered by Open Payments, Dr. Delengocky received a total of $3,326 from 21 pharmaceutical and/or device companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Delengocky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 11% volume in CA $3,326 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,395
Medicare services
Top 11% in CA for ophthalmology
6,829
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~466 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
1,449 $27 $125
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
1,368 $101 $250
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
998 $30 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
922 $51 $120
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
636 $26 $100
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
621 $106 $190
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
421 $48 $180
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
368 $86 $800
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
330 $73 $145
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
328 $80 $175
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
327 $70 $325
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
172 $92 $250
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
118 $173 $577
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
71 $116 $260
Aflibercept eye injection (Eylea) 66 $688 $2,000
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
64 $7 $100
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
62 $263 $1,800
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
27 $14 $161
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $50 $180
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
15 $403 $1,200
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
14 $274 $900
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,326
Total received (2018-2024)
Avg $475/year across 7 years
Top 33% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
137
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,326 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,064
2023
$761
2022
$633
2021
$411
2020
$90
2019
$211
2018
$156

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$424
ABBVIE INC.
$164
Alcon Vision LLC
$160
SUN PHARMACEUTICAL INDUSTRIES INC.
$66
Oyster Point Pharma, Inc.
$62
Mallinckrodt Hospital Products Inc.
$54
ANI Pharmaceuticals, Inc.
$47
Dompe US, Inc.
$25
Tarsus Pharmaceuticals, Inc.
$24
Thea Pharma Inc.
$21
Harrow Eye, LLC
$17
Top 3 companies account for 70.3% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$424
Oyster Point Pharma, Inc.
$412
Sun Pharmaceutical Industries Inc.
$381
Aerie Pharmaceuticals, Inc.
$322
Alcon Vision LLC
$281
SUN PHARMACEUTICAL INDUSTRIES INC.
$247
ABBVIE INC.
$192
Horizon Therapeutics plc
$187
Mallinckrodt Hospital Products Inc.
$186
Dompe US, Inc.
$167
AbbVie Inc.
$154
Allergan, Inc.
$149
Shire North American Group Inc
$47
ANI Pharmaceuticals, Inc.
$47
Tarsus Pharmaceuticals, Inc.
$24
Kala Pharmaceuticals, Inc.
$24
Thea Pharma Inc.
$21
Harrow Eye, LLC
$17
Novartis Pharmaceuticals Corporation
$16
Boston Scientific Corporation
$14
Vyera Pharmaceuticals, LLC
$13
Top 3 companies account for 36.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · ARGOS · CEQUA · Cequa · Clareon · DURYSTA · Daraprim Tablet 25mg · INVELTYS · IYUZEH · LUMIGAN · MIEBO · OXERVATE · OZURDEX · PURIFIED CORTROPHIN GEL · RESTASIS MULTIDOSE · RYZUMVI · Rhopressa · Rocklatan · SUPERION · TEPEZZA · TYRVAYA · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XIIDRA · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Chula Vista?
Compare ophthalmologists in the Chula Vista area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
238
Per 100K population
7.2
County median income
$102,285
Nearest hospital
SHARP CHULA VISTA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Delengocky is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Delengocky experienced with retinal photography (fundus photo)?
Based on Medicare claims data, Dr. Delengocky performed 1,449 retinal photography (fundus photo) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Delengocky receive payments from pharmaceutical companies?
Yes. Dr. Delengocky received a total of $3,326 from 21 companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Delengocky's costs compare to other ophthalmologists in Chula Vista?
Dr. Delengocky's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Delengocky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →